| 1 |
[GO] |
2022―Sep―02 |
The United States Food Drug Administration’s Innovative Alternative Tools to Evaluate Good Clinical Practice During the COVID-19 Public Health Emergency |
Kassa Ayalew, Jenn Sellers, Phillip D. Kronstein, Laurie Muldowney, Emily Gebbia, Jean Mulinde, David Burrow |
| 2 |
[GO] |
2022―Jan―28 |
Institutional Change in Clinical Trials in the era of the COVID-19 Pandemic |
Tempei Miyaji, Takahiro Kiuchi,, Takuhiro Yamaguchi |